For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major depressive disorder. Early studies suggested promise, but enthusiasm faded after ...
Morning Overview on MSN
The same weight-loss drugs were linked to lower depression and anxiety
The same GLP-1 medications reshaping weight loss have been linked to lower rates of depression and anxiety, adding to a ...
Positive data on depression treatment based on a drug related to the psychedelic DMT is breathing life into shares of biotechs working on psychedelic medicines, after years of disappointments. Just as ...
In everyday language, the word depression is used in diverse ways and can refer to anything from passing feelings of sadness and unhappiness to chronic grief and deep despair. When clinicians and ...
Add Yahoo as a preferred source to see more of our stories on Google. Early evidence that a drug used for rheumatoid arthritis may reduce depression symptoms, fatigue, anxiety and increase overall ...
-- Reposted from the online magazine, "The Trauma & Mental Health Report" The pharmaceutical industry grosses over $300 billion a year in psychotropic medication sales. Included in this figure are ...
Certain SSRI medications, such as Lexapro or Prozac, have been approved for use in children for mental health conditions. Medication is often reserved for moderate-to-severe cases. It may work best ...
An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...
This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Janet Babin: Hey, Future of Everything listeners, it's Janet Babin. Earlier this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results